Effects of TACE combined with sorafenib on serum levels of HIF-1 alpha and OPN in patients with middle and advanced hepatocellular carcinoma

doi:10.3969/j.issn.1002-7386.2019.08.005

Home>Articles>Effects of TACE combined with sorafenib on serum levels of HIF-1 alpha and OPN in patients with middle and advanced hepatocellular carcinoma

DOI: 10.3969/j.issn.1002-7386.2019.08.005

Effects of TACE combined with sorafenib on serum levels of HIF-1 alpha and OPN in patients with middle and advanced hepatocellular carcinoma

Machine-generated Keywords：

Publication Date：2019-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 1144-1147 )

Hebei Medical Journal

ISTIC

ISSN：1002-7386

Year, Vol.(Issue)：2019,41(8)